National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

CMV N495 peptide
A nonapeptide consisting of amino acid residues 495-503 of the cytomegalovirus (CMV) internal matrix protein pp65 with immunostimulating activity. CMV N495 peptide may used as a control to gauge immunocompetence in individuals receiving cancer vaccines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:clomiphene citrate, clopidogrel bisulfate, Cloretazine, clotrimazole, CMF regimen
Next:CMV pp65 peptide, CMVpp65-A*0201 peptide vaccine, CNGRC peptide-TNF alpha conjugate, Co-Rax, Cocculus/nux vomica/tabacum/petroleum extract

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov